|
CRCP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.495980E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.739300E-03 |
| Normal-vs-Stage2 |
4.363000E-01 |
| Normal-vs-Stage3 |
3.213500E-04 |
| Normal-vs-Stage4 |
2.139000E-03 |
| Stage1-vs-Stage2 |
2.123400E-01 |
| Stage1-vs-Stage3 |
9.981800E-02 |
| Stage1-vs-Stage4 |
2.765800E-01 |
| Stage2-vs-Stage3 |
2.448000E-02 |
| Stage2-vs-Stage4 |
7.297600E-02 |
| Stage3-vs-Stage4 |
8.836000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.599400E-04 |
| Normal-vs-AfricanAmerican |
6.614000E-01 |
| Normal-vs-Asian |
6.659500E-03 |
| Caucasian-vs-AfricanAmerican |
5.910000E-02 |
| Caucasian-vs-Asian |
8.708400E-01 |
| AfricanAmerican-vs-Asian |
1.240610E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.636400E-03 |
| Normal-vs-Female |
2.338400E-03 |
| Male-vs-Female |
8.218800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.798800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.677000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.185600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.904020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.286600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.904200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.963400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.544200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.574400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.924400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.197590E-04 |
| Classical-VS-Follicular |
9.556900E-03 |
| Classical-VS-Other |
6.082200E-01 |
| Classical-VS-Normal |
3.883800E-03 |
| Tall-VS-Follicular |
5.05779999993017E-07 |
| Tall-VS-Other |
1.995230E-01 |
| Tall-VS-Normal |
2.77169999951532E-07 |
| Follicular-VS-Other |
2.297000E-01 |
| Follicular-VS-Normal |
8.568400E-01 |
| Other-VS-Normal |
7.609700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.549700E-02 |
| Normal-vs-N1 |
3.87170000000214E-05 |
| N0-vs-N1 |
1.092290E-02 |
|
|
